Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Divestments (2020 - 2021)

Standard Biotools (LAB) has disclosed Divestments for 2 consecutive years, with $2.0 million as the latest value for Q3 2021.

  • Quarterly Divestments fell 82.06% to $2.0 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2022, down 87.41% year-over-year, with the annual reading at $1.3 million for FY2021, 93.73% down from the prior year.
  • Divestments for Q3 2021 was $2.0 million at Standard Biotools, roughly flat from $2.0 million in the prior quarter.
  • The five-year high for Divestments was $11.2 million in Q3 2020, with the low at $2.0 million in Q1 2021.